In April 2004 our lives were forever changed when our
son was diagnosed with Stage Four Alveolar Rhabdomyosarcoma - a particularly virulent and high-risk
soft tissue tumor. Most of the doctors we initially visited offered treatment with the standard chemotherapy regimen,
which had an associated survival rate of no better than 25%. Luckily for us, we were able to enroll in a groundbreaking
clinical trial at Memorial Sloan-Kettering Cancer Center, and our son is now two years post diagnosis and in remission.
As a result of our
experience, we have established
The Cowboy Fund